C12N 2770/24223
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2770/24223 (Virus like particles [vlp]) appears on 12 US grants and 24 published applications in this corpus.
Search patents in C12N- Granted patents
- 12
- Published applications
- 24
- Assignees
- 27
- Inventors
- 62
- Latest grant
- 16 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 0 |
| 2003 | 0 | 4 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 1 | 2 |
| 2007 | 1 | 2 |
| 2008 | 1 | 0 |
| 2009 | 1 | 2 |
| 2010 | 0 | 1 |
| 2011 | 1 | 2 |
| 2012 | 1 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
| 2015 | 0 | 2 |
| 2016 | 0 | 2 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method of purifying whole virus particles16 Dec 2025US 12,497,598 B2Hvidovre Hospital
- Method for detecting protein-protein interactions in a cell utilizing particle-forming polypeptide-bait fusion proteins and virus-like particles1 Feb 2022US 11,237,174 B2Universiteit Gent
- Trapping mammalian protein-protein complexes in virus-like particles utilizing HIV-1 GAG-bait fusion proteins15 Oct 2019US 10,444,245 B2Universiteit Gent
- Fusion proteins and use thereof for preparing hepatitis C vaccines1 Jul 2014US 8,765,143 B2Universite Francois Rabelais De Tours
- Recombinant human hepatitis C virus-like particle and method for producing the same22 May 2012US 8,183,044 B2Japan AS Represented By Director-General of National Institute of Infectious Diseases
- Vsv vector-encoded hcv envelope proteins e1/e2 as vaccines against hepatitis c virus15 Jan 2026US 2026/0015593 A1Twincore Zentrum FüR Experimentelle Und Klinische Infektionsforschung GmbH
- Self-cleaving polyproteins and uses thereof6 Nov 2025US 2025/0339512 A1The University of Melbourne
- Method of purifying whole virus particles31 Aug 2023US 2023/0272350 A1Hvidovre Hospital
- Viral particle-based protein-protein interaction30 Jan 2020US 2020/0033357 A1Universiteit Gent
- Use of rapamycin as vaccine adjuvant and preparation method therefor29 Sep 2016US 2016/0279236 A1Institut Pasteur of Shanghai, Chinese Academy of Sciences
Most cited
By later US patents
- Core-glycosylated HCV envelope proteins14US 7,238,356 B2Innogenetics N. V. · 2007
- Synthesis and purification of hepatitis C virus-like particles12US 6,387,662 B1The United States of America as represented by the Department of Health and Human Services · 2002
- Expression of core-glycosylated HCV envelope proteins in yeast9US 7,048,930 B2Innogenetics N. V. · 2006
- Constructs and methods for expression of recombinant HCV envelope proteins5US 7,314,925 B2Innogenetics N. V. · 2008
- Trapping mammalian protein-protein complexes in virus-like particles utilizing HIV-1 GAG-bait fusion proteins1US 10,444,245 B2Universiteit Gent · 2019